@ARTICLE{Wang2016-sz,
  title       = "A Practical Guide to The Cancer Genome Atlas ({TCGA})",
  author      = "Wang, Zhining and Jensen, Mark A and Zenklusen, Jean Claude",
  affiliation = "Center for Cancer Genomics, National Cancer Institute,
                 National Institutes of Health, 31 Center Drive, Bethesda, MD,
                 USA. zhining.wang@nih.gov. Research Administration
                 Directorate, Leidos Biomedical Research Inc., Frederick
                 National Laboratory for Cancer Research, 8560 Progress Drive,
                 Frederick, 21701, MD, USA. Center for Cancer Genomics,
                 National Cancer Institute, National Institutes of Health, 31
                 Center Drive, Bethesda, MD, USA.",
  abstract    = "The Cancer Genome Atlas (TCGA) is one of the most ambitious
                 and successful cancer genomics programs to date. The TCGA
                 program has generated, analyzed, and made available genomic
                 sequence, expression, methylation, and copy number variation
                 data on over 11,000 individuals who represent over 30
                 different types of cancer. This chapter provides a brief
                 overview of the TCGA program and detailed instructions and
                 tips for investigators on how to find, access, and download
                 this data.",
  journal     = "Methods Mol. Biol.",
  volume      =  1418,
  pages       = "111--141",
  year        =  2016,
  keywords    = "Cancer genomics; Copy number; Methylation; Mutation;
                 Next-generation sequencing; Proteomics; TCGA; The Cancer
                 Genome Atlas; Transcriptome; miRNA"
}

@misc{Zenklusen2016-ab,
  title = {The Cancer Genome Atlas: More Than a Large Collection of Data},
  author = "Jean Claude Zencklsen",
  howpublished = {\url{http://http://cancergenome.nih.gov/researchhighlights/leadershipupdate/Impact\_JC\_Zenklusen.}},
  note = {Accessed: May 5, 2016}
}


@ARTICLE{McGranahan2016-tt,
  title       = "Clonal neoantigens elicit {T} cell immunoreactivity and
                 sensitivity to immune checkpoint blockade",
  author      = "McGranahan, Nicholas and Furness, Andrew J S and Rosenthal,
                 Rachel and Ramskov, Sofie and Lyngaa, Rikke and Saini, Sunil
                 Kumar and Jamal-Hanjani, Mariam and Wilson, Gareth A and
                 Birkbak, Nicolai J and Hiley, Crispin T and Watkins, Thomas B
                 K and Shafi, Seema and Murugaesu, Nirupa and Mitter, Richard
                 and Akarca, Ayse U and Linares, Joseph and Marafioti, Teresa
                 and Henry, Jake Y and Van Allen, Eliezer M and Miao, Diana and
                 Schilling, Bastian and Schadendorf, Dirk and Garraway, Levi A
                 and Makarov, Vladimir and Rizvi, Naiyer A and Snyder,
                 Alexandra and Hellmann, Matthew D and Merghoub, Taha and
                 Wolchok, Jedd D and Shukla, Sachet A and Wu, Catherine J and
                 Peggs, Karl S and Chan, Timothy A and Hadrup, Sine R and
                 Quezada, Sergio A and Swanton, Charles",
  affiliation = "The Francis Crick Institute, London WC2A 3LY, UK. Centre for
                 Mathematics and Physics in the Life Sciences and Experimental
                 Biology (CoMPLEX), University College London (UCL), London
                 WC1E 6BT, UK. Cancer Research UK Lung Cancer Centre of
                 Excellence, UCL Cancer Institute, London WC1E 6BT, UK. Cancer
                 Research UK Lung Cancer Centre of Excellence, UCL Cancer
                 Institute, London WC1E 6BT, UK. Cancer Immunology Unit, UCL
                 Cancer Institute, UCL, London WC1E 6BT, UK. Cancer Research UK
                 Lung Cancer Centre of Excellence, UCL Cancer Institute, London
                 WC1E 6BT, UK. Section for Immunology and Vaccinology, National
                 Veterinary Institute, Technical University of Denmark, 1970
                 Frederiksberg C, Denmark. Section for Immunology and
                 Vaccinology, National Veterinary Institute, Technical
                 University of Denmark, 1970 Frederiksberg C, Denmark. Section
                 for Immunology and Vaccinology, National Veterinary Institute,
                 Technical University of Denmark, 1970 Frederiksberg C,
                 Denmark. Cancer Research UK Lung Cancer Centre of Excellence,
                 UCL Cancer Institute, London WC1E 6BT, UK. The Francis Crick
                 Institute, London WC2A 3LY, UK. Cancer Research UK Lung Cancer
                 Centre of Excellence, UCL Cancer Institute, London WC1E 6BT,
                 UK. The Francis Crick Institute, London WC2A 3LY, UK. Cancer
                 Research UK Lung Cancer Centre of Excellence, UCL Cancer
                 Institute, London WC1E 6BT, UK. The Francis Crick Institute,
                 London WC2A 3LY, UK. Cancer Research UK Lung Cancer Centre of
                 Excellence, UCL Cancer Institute, London WC1E 6BT, UK. The
                 Francis Crick Institute, London WC2A 3LY, UK. Cancer Research
                 UK Lung Cancer Centre of Excellence, UCL Cancer Institute,
                 London WC1E 6BT, UK. Cancer Research UK Lung Cancer Centre of
                 Excellence, UCL Cancer Institute, London WC1E 6BT, UK. Cancer
                 Research UK Lung Cancer Centre of Excellence, UCL Cancer
                 Institute, London WC1E 6BT, UK. The Francis Crick Institute,
                 London WC2A 3LY, UK. Cancer Immunology Unit, UCL Cancer
                 Institute, UCL, London WC1E 6BT, UK. Department of Cellular
                 Pathology, UCL, London WC1E 6BT, UK. Cancer Immunology Unit,
                 UCL Cancer Institute, UCL, London WC1E 6BT, UK. Department of
                 Cellular Pathology, UCL, London WC1E 6BT, UK. Cancer
                 Immunology Unit, UCL Cancer Institute, UCL, London WC1E 6BT,
                 UK. Department of Cellular Pathology, UCL, London WC1E 6BT,
                 UK. Cancer Research UK Lung Cancer Centre of Excellence, UCL
                 Cancer Institute, London WC1E 6BT, UK. Cancer Immunology Unit,
                 UCL Cancer Institute, UCL, London WC1E 6BT, UK. Department of
                 Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
                 02215, USA. Broad Institute of MIT and Harvard, Cambridge, MA
                 02142, USA. Center for Cancer Precision Medicine, Dana-Farber
                 Cancer Institute, Boston, MA 02215, USA. Department of Medical
                 Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
                 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
                 Department of Dermatology, University Hospital, University
                 Duisburg-Essen, 45147 Essen, Germany. German Cancer Consortium
                 (DKTK), 69121 Heidelberg, Germany. Department of Dermatology,
                 University Hospital, University Duisburg-Essen, 45147 Essen,
                 Germany. German Cancer Consortium (DKTK), 69121 Heidelberg,
                 Germany. Department of Medical Oncology, Dana-Farber Cancer
                 Institute, Boston, MA 02215, USA. Broad Institute of MIT and
                 Harvard, Cambridge, MA 02142, USA. Center for Cancer Precision
                 Medicine, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
                 Human Oncology and Pathogenesis Program, Memorial Sloan
                 Kettering Cancer Center, New York, NY 10065, USA.
                 Hematology/Oncology Division, 177 Fort Washington Avenue,
                 Columbia University, New York, NY 10032, USA. Department of
                 Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
                 10065, USA. Weill Cornell Medical College, New York, NY 10065,
                 USA. Department of Medicine, Memorial Sloan Kettering Cancer
                 Center, New York, NY 10065, USA. Weill Cornell Medical
                 College, New York, NY 10065, USA. Department of Medicine,
                 Memorial Sloan Kettering Cancer Center, New York, NY 10065,
                 USA. Ludwig Collaborative Laboratory, Memorial Sloan Kettering
                 Cancer Center, New York, NY 10065, USA. Department of
                 Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
                 10065, USA. Weill Cornell Medical College, New York, NY 10065,
                 USA. Ludwig Collaborative Laboratory, Memorial Sloan Kettering
                 Cancer Center, New York, NY 10065, USA. Department of Medical
                 Oncology, Dana-Farber Cancer Institute, Boston, MA 02215, USA.
                 Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
                 Department of Medical Oncology, Dana-Farber Cancer Institute,
                 Boston, MA 02215, USA. Broad Institute of MIT and Harvard,
                 Cambridge, MA 02142, USA. Department of Medicine, Harvard
                 Medical School, Boston, MA 02115, USA. Department of Internal
                 Medicine, Brigham and Woman's Hospital, Boston, MA 02115, USA.
                 Cancer Research UK Lung Cancer Centre of Excellence, UCL
                 Cancer Institute, London WC1E 6BT, UK. Cancer Immunology Unit,
                 UCL Cancer Institute, UCL, London WC1E 6BT, UK. Human Oncology
                 and Pathogenesis Program, Memorial Sloan Kettering Cancer
                 Center, New York, NY 10065, USA. Section for Immunology and
                 Vaccinology, National Veterinary Institute, Technical
                 University of Denmark, 1970 Frederiksberg C, Denmark. Cancer
                 Research UK Lung Cancer Centre of Excellence, UCL Cancer
                 Institute, London WC1E 6BT, UK. Cancer Immunology Unit, UCL
                 Cancer Institute, UCL, London WC1E 6BT, UK.
                 s.quezada@ucl.ac.uk charles.swanton@crick.ac.uk. The Francis
                 Crick Institute, London WC2A 3LY, UK. Cancer Research UK Lung
                 Cancer Centre of Excellence, UCL Cancer Institute, London WC1E
                 6BT, UK. s.quezada@ucl.ac.uk charles.swanton@crick.ac.uk.",
  abstract    = "As tumors grow, they acquire mutations, some of which create
                 neoantigens that influence the response of patients to immune
                 checkpoint inhibitors. We explored the impact of neoantigen
                 intratumor heterogeneity (ITH) on antitumor immunity. Through
                 integrated analysis of ITH and neoantigen burden, we
                 demonstrate a relationship between clonal neoantigen burden
                 and overall survival in primary lung adenocarcinomas.
                 CD8(+)tumor-infiltrating lymphocytes reactive to clonal
                 neoantigens were identified in early-stage non-small cell lung
                 cancer and expressed high levels of PD-1. Sensitivity to PD-1
                 and CTLA-4 blockade in patients with advanced NSCLC and
                 melanoma was enhanced in tumors enriched for clonal
                 neoantigens. T cells recognizing clonal neoantigens were
                 detectable in patients with durable clinical benefit.
                 Cytotoxic chemotherapy-induced subclonal neoantigens,
                 contributing to an increased mutational load, were enriched in
                 certain poor responders. These data suggest that neoantigen
                 heterogeneity may influence immune surveillance and support
                 therapeutic developments targeting clonal neoantigens.",
  journal     = "Science",
  volume      =  351,
  number      =  6280,
  pages       = "1463--1469",
  month       =  "25~" # mar,
  year        =  2016,
  url         = "http://dx.doi.org/10.1126/science.aaf1490",
  language    = "en",
  issn        = "0036-8075, 1095-9203",
  pmid        = "26940869",
  doi         = "10.1126/science.aaf1490"
}


@ARTICLE{Fumagalli2015-tl,
  title       = "Principles Governing {A-to-I} {RNA} Editing in the Breast
                 Cancer Transcriptome",
  author      = "Fumagalli, Debora and Gacquer, David and Roth\'{e},
                 Fran\c{c}oise and Lefort, Anne and Libert, Frederick and
                 Brown, David and Kheddoumi, Naima and Shlien, Adam and
                 Konopka, Tomasz and Salgado, Roberto and Larsimont, Denis and
                 Polyak, Kornelia and Willard-Gallo, Karen and Desmedt,
                 Christine and Piccart, Martine and Abramowicz, Marc and
                 Campbell, Peter J and Sotiriou, Christos and Detours, Vincent",
  affiliation = "Breast Cancer Translational Research Laboratory, Jules Bordet
                 Institute, Universit\'{e} Libre de Bruxelles (ULB), Boulevard
                 de Waterloo, 125-1000 Brussels, Belgium. IRIBHM,
                 Universit\'{e} Libre de Bruxelles (ULB), Route de Lennik,
                 808-1070 Brussels, Belgium. Breast Cancer Translational
                 Research Laboratory, Jules Bordet Institute, Universit\'{e}
                 Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000
                 Brussels, Belgium. IRIBHM, Universit\'{e} Libre de Bruxelles
                 (ULB), Route de Lennik, 808-1070 Brussels, Belgium. IRIBHM,
                 Universit\'{e} Libre de Bruxelles (ULB), Route de Lennik,
                 808-1070 Brussels, Belgium. Breast Cancer Translational
                 Research Laboratory, Jules Bordet Institute, Universit\'{e}
                 Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000
                 Brussels, Belgium. Breast Cancer Translational Research
                 Laboratory, Jules Bordet Institute, Universit\'{e} Libre de
                 Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels,
                 Belgium. Cancer Genome Project, Wellcome Trust Sanger
                 Institute, Wellcome Trust Genome Campus, Hinxton,
                 Cambridgeshire CB10 1SA, UK. IRIBHM, Universit\'{e} Libre de
                 Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium.
                 Breast Cancer Translational Research Laboratory, Jules Bordet
                 Institute, Universit\'{e} Libre de Bruxelles (ULB), Boulevard
                 de Waterloo, 125-1000 Brussels, Belgium. Department of
                 Pathology, Jules Bordet Institute, Universit\'{e} Libre de
                 Bruxelles (ULB), Boulevard de Waterloo, 125-1000 Brussels,
                 Belgium. Department of Medical Oncology, Dana-Farber Cancer
                 Institute, 450 Brookline Avenue, Boston, MA 02215, USA.
                 Molecular Immunology Unit, Jules Bordet Institute,
                 Universit\'{e} Libre de Bruxelles (ULB), Boulevard de
                 Waterloo, 125-1000 Brussels, Belgium. Breast Cancer
                 Translational Research Laboratory, Jules Bordet Institute,
                 Universit\'{e} Libre de Bruxelles (ULB), Boulevard de
                 Waterloo, 125-1000 Brussels, Belgium. Department of Medicine,
                 Jules Bordet Institute, Universit\'{e} Libre de Bruxelles
                 (ULB), Boulevard de Waterloo, 125-1000 Brussels, Belgium.
                 Department of Genetics, H\^{o}pital Erasme, Route de Lennik,
                 808-1070 Brussels, Belgium. Cancer Genome Project, Wellcome
                 Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton,
                 Cambridgeshire CB10 1SA, UK. Breast Cancer Translational
                 Research Laboratory, Jules Bordet Institute, Universit\'{e}
                 Libre de Bruxelles (ULB), Boulevard de Waterloo, 125-1000
                 Brussels, Belgium; Department of Medicine, Jules Bordet
                 Institute, Universit\'{e} Libre de Bruxelles (ULB), Boulevard
                 de Waterloo, 125-1000 Brussels, Belgium. Electronic address:
                 christos.sotiriou@bordet.be. IRIBHM, Universit\'{e} Libre de
                 Bruxelles (ULB), Route de Lennik, 808-1070 Brussels, Belgium;
                 WELBIO, Route de Lennik, 808-1070 Brussels, Belgium.
                 Electronic address: vdetours@ulb.ac.be.",
  abstract    = "Little is known about how RNA editing operates in cancer.
                 Transcriptome analysis of 68 normal and cancerous breast
                 tissues revealed that the editing enzyme ADAR acts uniformly,
                 on the same loci, across tissues. In controlled ADAR
                 expression experiments, the editing frequency increased at all
                 loci with ADAR expression levels according to the logistic
                 model. Loci-specific ``editabilities,'' i.e., propensities to
                 be edited by ADAR, were quantifiable by fitting the logistic
                 function to dose-response data. The editing frequency was
                 increased in tumor cells in comparison to normal controls.
                 Type I interferon response and ADAR DNA copy number together
                 explained 53\% of ADAR expression variance in breast cancers.
                 ADAR silencing using small hairpin RNA lentivirus transduction
                 in breast cancer cell lines led to less cell proliferation and
                 more apoptosis. A-to-I editing is a pervasive, yet
                 reproducible, source of variation that is globally controlled
                 by 1q amplification and inflammation, both of which are highly
                 prevalent among human cancers.",
  journal     = "Cell reports",
  volume      =  13,
  number      =  2,
  pages       = "277--289",
  month       =  "13~" # oct,
  year        =  2015,
  url         = "http://dx.doi.org/10.1016/j.celrep.2015.09.032",
  file        = "All Papers/F/Fumagalli et al. 2015 - Principles Governing A-to-I RNA Editing in the Breast Cancer Transcriptome.pdf",
  language    = "en",
  issn        = "2211-1247",
  pmid        = "26440892",
  doi         = "10.1016/j.celrep.2015.09.032"
}


@ARTICLE{Han2015-hl,
  title       = "The Genomic Landscape and Clinical Relevance of {A-to-I} {RNA}
                 Editing in Human Cancers",
  author      = "Han, Leng and Diao, Lixia and Yu, Shuangxing and Xu, Xiaoyan
                 and Li, Jie and Zhang, Rui and Yang, Yang and Werner, Henrica
                 M J and Eterovic, A Karina and Yuan, Yuan and Li, Jun and
                 Nair, Nikitha and Minelli, Rosalba and Tsang, Yiu Huen and
                 Cheung, Lydia W T and Jeong, Kang Jin and Roszik, Jason and
                 Ju, Zhenlin and Woodman, Scott E and Lu, Yiling and Scott,
                 Kenneth L and Li, Jin Billy and Mills, Gordon B and Liang, Han",
  affiliation = "Department of Bioinformatics and Computational Biology, The
                 University of Texas MD Anderson Cancer Center, Houston, TX
                 77030, USA. Department of Bioinformatics and Computational
                 Biology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA. Department of Systems Biology, The
                 University of Texas MD Anderson Cancer Center, Houston, TX
                 77030, USA. Department of Bioinformatics and Computational
                 Biology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA; Department of Pathophysiology, College
                 of Basic Medicine, China Medical University, Shenyang City,
                 Liaoning Province 110001, China. Department of Systems
                 Biology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA. Department of Genetics, Stanford
                 University, Stanford, CA 94305, USA. Department of
                 Bioinformatics and Computational Biology, The University of
                 Texas MD Anderson Cancer Center, Houston, TX 77030, USA;
                 Division of Biostatistics, The University of Texas Health
                 Science Center at Houston, School of Public Health, Houston TX
                 77030, USA. Department of Systems Biology, The University of
                 Texas MD Anderson Cancer Center, Houston, TX 77030, USA;
                 Women's Department, Haukeland University Hospital, Jonas
                 Liesvei 72, 5053 Bergen, Norway. Department of Systems
                 Biology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA. Department of Bioinformatics and
                 Computational Biology, The University of Texas MD Anderson
                 Cancer Center, Houston, TX 77030, USA. Department of
                 Bioinformatics and Computational Biology, The University of
                 Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
                 Department of Molecular and Human Genetics, Baylor College of
                 Medicine, Houston, TX 77030, USA. Department of Molecular and
                 Human Genetics, Baylor College of Medicine, Houston, TX 77030,
                 USA. Department of Molecular and Human Genetics, Baylor
                 College of Medicine, Houston, TX 77030, USA. Department of
                 Systems Biology, The University of Texas MD Anderson Cancer
                 Center, Houston, TX 77030, USA. Department of Systems Biology,
                 The University of Texas MD Anderson Cancer Center, Houston, TX
                 77030, USA. Department of Melanoma Medical Oncology, The
                 University of Texas MD Anderson Cancer Center, Houston, TX
                 77030, USA. Department of Bioinformatics and Computational
                 Biology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA. Department of Melanoma Medical
                 Oncology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA. Department of Systems Biology, The
                 University of Texas MD Anderson Cancer Center, Houston, TX
                 77030, USA. Department of Molecular and Human Genetics, Baylor
                 College of Medicine, Houston, TX 77030, USA. Department of
                 Genetics, Stanford University, Stanford, CA 94305, USA.
                 Department of Systems Biology, The University of Texas MD
                 Anderson Cancer Center, Houston, TX 77030, USA. Electronic
                 address: gmills@mdanderson.org. Department of Bioinformatics
                 and Computational Biology, The University of Texas MD Anderson
                 Cancer Center, Houston, TX 77030, USA; Department of Systems
                 Biology, The University of Texas MD Anderson Cancer Center,
                 Houston, TX 77030, USA. Electronic address:
                 hliang1@mdanderson.org.",
  abstract    = "Adenosine-to-inosine (A-to-I) RNA editing is a widespread
                 post-transcriptional mechanism, but its genomic landscape and
                 clinical relevance in cancer have not been investigated
                 systematically. We characterized the global A-to-I RNA editing
                 profiles of 6,236 patient samples of 17 cancer types from The
                 Cancer Genome Atlas and revealed a striking diversity of
                 altered RNA-editing patterns in tumors relative to normal
                 tissues. We identified an appreciable number of clinically
                 relevant editing events, many of which are in noncoding
                 regions. We experimentally demonstrated the effects of several
                 cross-tumor nonsynonymous RNA editing events on cell viability
                 and provide the evidence that RNA editing could selectively
                 affect drug sensitivity. These results highlight RNA editing
                 as an exciting theme for investigating cancer mechanisms,
                 biomarkers, and treatments.",
  journal     = "Cancer cell",
  volume      =  28,
  number      =  4,
  pages       = "515--528",
  month       =  "12~" # oct,
  year        =  2015,
  url         = "http://dx.doi.org/10.1016/j.ccell.2015.08.013",
  language    = "en",
  issn        = "1535-6108, 1878-3686",
  pmid        = "26439496",
  doi         = "10.1016/j.ccell.2015.08.013",
  pmc         = "PMC4605878"
}


@ARTICLE{Paz-Yaacov2015-gg,
  title       = "Elevated {RNA} Editing Activity Is a Major Contributor to
                 Transcriptomic Diversity in Tumors",
  author      = "Paz-Yaacov, Nurit and Bazak, Lily and Buchumenski, Ilana and
                 Porath, Hagit T and Danan-Gotthold, Miri and Knisbacher,
                 Binyamin A and Eisenberg, Eli and Levanon, Erez Y",
  affiliation = "The Mina and Everard Goodman Faculty of Life Sciences,
                 Bar-Ilan University, Ramat Gan 52900, Israel. The Mina and
                 Everard Goodman Faculty of Life Sciences, Bar-Ilan University,
                 Ramat Gan 52900, Israel. The Mina and Everard Goodman Faculty
                 of Life Sciences, Bar-Ilan University, Ramat Gan 52900,
                 Israel. The Mina and Everard Goodman Faculty of Life Sciences,
                 Bar-Ilan University, Ramat Gan 52900, Israel. The Mina and
                 Everard Goodman Faculty of Life Sciences, Bar-Ilan University,
                 Ramat Gan 52900, Israel. The Mina and Everard Goodman Faculty
                 of Life Sciences, Bar-Ilan University, Ramat Gan 52900,
                 Israel. School of Physics and Astronomy, Raymond and Beverly
                 Sackler Faculty of Exact Sciences, Tel Aviv University, Tel
                 Aviv 69978, Israel. Electronic address: elieis@post.tau.ac.il.
                 The Mina and Everard Goodman Faculty of Life Sciences,
                 Bar-Ilan University, Ramat Gan 52900, Israel. Electronic
                 address: erez.levanon@biu.ac.il.",
  abstract    = "Genomic mutations in key genes are known to drive
                 tumorigenesis and have been the focus of much attention in
                 recent years. However, genetic content also may change farther
                 downstream. RNA editing alters the mRNA sequence from its
                 genomic blueprint in a dynamic and flexible way. A few
                 isolated cases of editing alterations in cancer have been
                 reported previously. Here, we provide a transcriptome-wide
                 characterization of RNA editing across hundreds of cancer
                 samples from multiple cancer tissues, and we show that A-to-I
                 editing and the enzymes mediating this modification are
                 significantly altered, usually elevated, in most cancer types.
                 Increased editing activity is found to be associated with
                 patient survival. As is the case with somatic mutations in
                 DNA, most of these newly introduced RNA mutations are likely
                 passengers, but a few may serve as drivers that may be novel
                 candidates for therapeutic and diagnostic purposes.",
  journal     = "Cell reports",
  volume      =  13,
  number      =  2,
  pages       = "267--276",
  month       =  "13~" # oct,
  year        =  2015,
  url         = "http://dx.doi.org/10.1016/j.celrep.2015.08.080",
  file        = "All Papers/P/Paz-Yaacov et al. 2015 - Elevated RNA Editing Activity Is a Major Contributor to Transcriptomic Diversity in Tumors.pdf",
  language    = "en",
  issn        = "2211-1247",
  pmid        = "26440895",
  doi         = "10.1016/j.celrep.2015.08.080"
}


@ARTICLE{Grieb2014-xs,
  title    = "{MTBP} is Over-expressed in Triple Negative Breast Cancer and
              Contributes to its Growth and Survival",
  author   = "Grieb, Brian C and Chen, Xi and Eischen, Christine M",
  abstract = "Triple negative breast cancer (TNBC) is a clinically aggressive
              subtype of breast cancer commonly resistant to therapeutics that
              have been successful in increasing survival in ER+ and HER2+
              breast cancer patients. As such, identifying factors that
              contribute to poor patient outcomes and mediate the growth and
              survival of TNBC cells remain important areas of investigation.
              MTBP (MDM2 Binding Protein), a gene linked to cellular
              proliferation and a transcriptional target of the MYC oncogene,
              is over-expressed in human malignancies, yet its contribution to
              cancer remains unresolved. Evaluation of mRNA expression and copy
              number variation data from The Cancer Genome Atlas (TCGA)
              revealed MTBP is commonly overexpressed in breast cancer and 19\%
              show amplification of MTBP. Increased transcript or gene
              amplification of MTBP significantly correlated with reduced
              breast cancer patient survival. Further analysis revealed that
              while MTBP mRNA is over-expressed in both ER+ and HER2+ breast
              cancers, its expression is highest in TNBC. MTBP mRNA and protein
              levels were also significantly elevated in a panel of human TNBC
              cell lines. Knockdown of MTBP in TNBC model systems induced
              apoptosis and significantly reduced TNBC cell growth and soft
              agar colony formation, which was rescued by expression of
              shRNA-resistant Mtbp. Notably, inducible knockdown of MTBP
              expression significantly impaired TNBC tumor growth, in vivo,
              including in established tumors. Thus, these data emphasize MTBP
              is important for the growth and survival of TNBC and warrants
              further investigation as a potential novel therapeutic target.
              Implications: MTBP significantly contributes to breast cancer
              survival and is a potential novel therapeutic target in TNBC.",
  journal  = "Molecular cancer research: MCR",
  month    =  "27~" # may,
  year     =  2014,
  url      = "http://mcr.aacrjournals.org/content/early/2014/05/24/1541-7786.MCR-14-0069.abstract",
  annote   = "10.1158/1541-7786.MCR-14-0069",
  file     = "All Papers/G/Grieb et al. 2014 - MTBP is Over-expressed in Triple Negative Breast Cancer and Contributes to its Growth and Survival.pdf",
  issn     = "1541-7786",
  doi      = "10.1158/1541-7786.MCR-14-0069"
}


@ARTICLE{Grabiner2014-go,
  title       = "A diverse array of cancer-associated {MTOR} mutations are
                 hyperactivating and can predict rapamycin sensitivity",
  author      = "Grabiner, Brian C and Nardi, Valentina and Birsoy, K\i{}vanc
                 and Possemato, Richard and Shen, Kuang and Sinha, Sumi and
                 Jordan, Alexander and Beck, Andrew H and Sabatini, David M",
  affiliation = "1Whitehead Institute for Biomedical Research; 2Howard Hughes
                 Medical Institute and Department of Biology, MIT; 3Broad
                 Institute of Harvard and MIT; 4The David H. Koch Institute for
                 Integrative Cancer Research at MIT, Cambridge; 5Department of
                 Pathology, Massachusetts General Hospital Cancer Center; and
                 6Department of Pathology, Beth Israel Deaconess Medical
                 Center, Harvard Medical School, Boston, Massachusetts.",
  abstract    = "Genes encoding components of the PI3K-AKT-mTOR signaling axis
                 are frequently mutated in cancer, but few mutations have been
                 characterized in MTOR, the gene encoding the mTOR kinase.
                 Using publicly available tumor genome sequencing data, we
                 generated a comprehensive catalog of mTOR pathway mutations in
                 cancer, identifying 33 MTOR mutations that confer pathway
                 hyperactivation. The mutations cluster in six distinct regions
                 in the C-terminal half of mTOR and occur in multiple cancer
                 types, with one cluster particularly prominent in kidney
                 cancer. The activating mutations do not affect mTOR complex
                 assembly, but a subset reduces binding to the mTOR inhibitor
                 DEPTOR. mTOR complex 1 (mTORC1) signaling in cells expressing
                 various activating mutations remains sensitive to
                 pharmacologic mTOR inhibition, but is partially resistant to
                 nutrient deprivation. Finally, cancer cell lines with
                 hyperactivating MTOR mutations display heightened sensitivity
                 to rapamycin both in culture and in vivo xenografts,
                 suggesting that such mutations confer mTOR pathway dependency.",
  journal     = "Cancer discovery",
  volume      =  4,
  number      =  5,
  pages       = "554--563",
  month       =  may,
  year        =  2014,
  url         = "http://dx.doi.org/10.1158/2159-8290.CD-13-0929",
  file        = "All Papers/G/Grabiner et al. 2014 - A diverse array of cancer-associated MTOR mutations are hyperactivating and can predict rapamycin sensitivity.pdf",
  language    = "en",
  issn        = "2159-8274, 2159-8290",
  pmid        = "24631838",
  doi         = "10.1158/2159-8290.CD-13-0929",
  pmc         = "PMC4012430"
}



@ARTICLE{Wagle2014-cl,
  title       = "Activating {mTOR} mutations in a patient with an extraordinary
                 response on a phase {I} trial of everolimus and pazopanib",
  author      = "Wagle, Nikhil and Grabiner, Brian C and Van Allen, Eliezer M
                 and Hodis, Eran and Jacobus, Susanna and Supko, Jeffrey G and
                 Stewart, Michelle and Choueiri, Toni K and Gandhi, Leena and
                 Cleary, James M and Elfiky, Aymen A and Taplin, Mary Ellen and
                 Stack, Edward C and Signoretti, Sabina and Loda, Massimo and
                 Shapiro, Geoffrey I and Sabatini, David M and Lander, Eric S
                 and Gabriel, Stacey B and Kantoff, Philip W and Garraway, Levi
                 A and Rosenberg, Jonathan E",
  affiliation = "Departments of 1Medical Oncology and 2Biostatistics and
                 Computational Biology, 3Center for Molecular Oncologic
                 Pathology, Dana-Farber Cancer Institute; Departments of
                 4Medicine and 5Pathology, Brigham and Women's Hospital,
                 Harvard Medical School; 6Division of Hematology/Oncology,
                 Massachusetts General Hospital, Boston; 7Broad Institute of
                 Harvard and MIT; 8Department of Biology, Whitehead Institute
                 for Biomedical Research; 9Howard Hughes Medical Institute,
                 Massachusetts Institute of Technology, Cambridge,
                 Massachusetts; and 10Department of Medicine, Memorial
                 Sloan-Kettering Cancer Center, New York, New York.",
  abstract    = "Understanding the genetic mechanisms of sensitivity to
                 targeted anticancer therapies may improve patient selection,
                 response to therapy, and rational treatment designs. One
                 approach to increase this understanding involves detailed
                 studies of exceptional responders: rare patients with
                 unexpected exquisite sensitivity or durable responses to
                 therapy. We identified an exceptional responder in a phase I
                 study of pazopanib and everolimus in advanced solid tumors.
                 Whole-exome sequencing of a patient with a 14-month complete
                 response on this trial revealed two concurrent mutations in
                 mTOR, the target of everolimus. In vitro experiments
                 demonstrate that both mutations are activating, suggesting a
                 biologic mechanism for exquisite sensitivity to everolimus in
                 this patient. The use of precision (or ``personalized'')
                 medicine approaches to screen patients with cancer for
                 alterations in the mTOR pathway may help to identify subsets
                 of patients who may benefit from targeted therapies directed
                 against mTOR.",
  journal     = "Cancer discovery",
  volume      =  4,
  number      =  5,
  pages       = "546--553",
  month       =  may,
  year        =  2014,
  url         = "http://dx.doi.org/10.1158/2159-8290.CD-13-0353",
  file        = "All Papers/W/Wagle et al. 2014 - Activating mTOR mutations in a patient with an extraordinary response on a phase I trial of everolimus and pazopanib.pdf",
  language    = "en",
  issn        = "2159-8274, 2159-8290",
  pmid        = "24625776",
  doi         = "10.1158/2159-8290.CD-13-0353",
  pmc         = "PMC4122326"
}


@ARTICLE{Cancer_Genome_Atlas_Network2012-nz,
  title    = "Comprehensive molecular portraits of human breast tumours",
  author   = "{Cancer Genome Atlas Network}",
  abstract = "We analysed primary breast cancers by genomic DNA copy number
              arrays, DNA methylation, exome sequencing, messenger RNA arrays,
              microRNA sequencing and reverse-phase protein arrays. Our ability
              to integrate information across platforms provided key insights
              into previously defined gene expression subtypes and demonstrated
              the existence of four main breast cancer classes when combining
              data from five platforms, each of which shows significant
              molecular heterogeneity. Somatic mutations in only three genes
              (TP53, PIK3CA and GATA3) occurred at >10\% incidence across all
              breast cancers; however, there were numerous subtype-associated
              and novel gene mutations including the enrichment of specific
              mutations in GATA3, PIK3CA and MAP3K1 with the luminal A subtype.
              We identified two novel protein-expression-defined subgroups,
              possibly produced by stromal/microenvironmental elements, and
              integrated analyses identified specific signalling pathways
              dominant in each molecular subtype including a
              HER2/phosphorylated HER2/EGFR/phosphorylated EGFR signature
              within the HER2-enriched expression subtype. Comparison of
              basal-like breast tumours with high-grade serous ovarian tumours
              showed many molecular commonalities, indicating a related
              aetiology and similar therapeutic opportunities. The biological
              finding of the four main breast cancer subtypes caused by
              different subsets of genetic and epigenetic abnormalities raises
              the hypothesis that much of the clinically observable plasticity
              and heterogeneity occurs within, and not across, these major
              biological subtypes of breast cancer.",
  journal  = "Nature",
  volume   =  490,
  number   =  7418,
  pages    = "61--70",
  month    =  "4~" # oct,
  year     =  2012,
  url      = "http://dx.doi.org/10.1038/nature11412",
  file     = "All Papers/C/Cancer Genome Atlas Network 2012 - Comprehensive molecular portraits of human breast tumours.pdf",
  language = "en",
  issn     = "0028-0836, 1476-4687",
  pmid     = "23000897",
  doi      = "10.1038/nature11412",
  pmc      = "PMC3465532"
}


@ARTICLE{Schroeder2013-hd,
  title    = "Visualizing multidimensional cancer genomics data",
  author   = "Schroeder, Michael P and Gonzalez-Perez, Abel and Lopez-Bigas,
              Nuria",
  abstract = "Cancer genomics projects employ high-throughput technologies to
              identify the complete catalog of somatic alterations that
              characterize the genome, transcriptome and epigenome of cohorts
              of tumor samples. Examples include projects carried out by the
              International Cancer Genome Consortium (ICGC) and The Cancer
              Genome Atlas (TCGA). A crucial step in the extraction of
              knowledge from the data is the exploration by experts of the
              different alterations, as well as the multiple relationships
              between them. To that end, the use of intuitive visualization
              tools that can integrate different types of alterations with
              clinical data is essential to the field of cancer genomics. Here,
              we review effective and common visualization techniques for
              exploring oncogenomics data and discuss a selection of tools that
              allow researchers to effectively visualize multidimensional
              oncogenomics datasets. The review covers visualization methods
              employed by tools such as Circos, Gitools, the Integrative
              Genomics Viewer, Cytoscape, Savant Genome Browser, StratomeX and
              platforms such as cBio Cancer Genomics Portal, IntOGen, the UCSC
              Cancer Genomics Browser, the Regulome Explorer and the Cancer
              Genome Workbench.",
  journal  = "Genome medicine",
  volume   =  5,
  number   =  1,
  pages    = "9",
  month    =  jan,
  year     =  2013,
  url      = "http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3706894&tool=pmcentrez&rendertype=abstract",
  file     = "All Papers/S/Schroeder et al. 2013 - Visualizing multidimensional cancer genomics data.pdf",
  issn     = "1756-994X",
  pmid     = "23363777",
  doi      = "10.1186/gm413"
}


@ARTICLE{Nielsen2010-ch,
  title    = "Visualizing genomes: techniques and challenges",
  author   = "Nielsen, Cydney B and Cantor, Michael and Dubchak, Inna and
              Gordon, David and Wang, Ting",
  abstract = "As our ability to generate sequencing data continues to increase,
              data analysis is replacing data generation as the rate-limiting
              step in genomics studies. Here we provide a guide to genomic data
              visualization tools that facilitate analysis tasks by enabling
              researchers to explore, interpret and manipulate their data, and
              in some cases perform on-the-fly computations. We will discuss
              graphical methods designed for the analysis of de novo sequencing
              assemblies and read alignments, genome browsing, and comparative
              genomics, highlighting the strengths and limitations of these
              approaches and the challenges ahead.",
  journal  = "Nature methods",
  volume   =  7,
  number   = "3 Suppl",
  pages    = "S5--S15",
  month    =  mar,
  year     =  2010,
  url      = "http://www.ncbi.nlm.nih.gov/pubmed/20195257",
  keywords = "Computer Graphics; Genome; Image Processing, Computer-Assisted",
  issn     = "1548-7091, 1548-7105",
  pmid     = "20195257",
  doi      = "10.1038/nmeth.1422"
}


@ARTICLE{Wang2015-xx,
  title       = "Open source libraries and frameworks for biological data
                 visualisation: a guide for developers",
  author      = "Wang, Rui and Perez-Riverol, Yasset and Hermjakob, Henning and
                 Vizca\'{\i}no, Juan Antonio",
  affiliation = "European Molecular Biology Laboratory, European Bioinformatics
                 Institute (EMBL-EBI), Wellcome Trust Genome Campus, Hinxton,
                 Cambridge, UK.",
  abstract    = "Recent advances in high-throughput experimental techniques
                 have led to an exponential increase in both the size and the
                 complexity of the data sets commonly studied in biology. Data
                 visualisation is increasingly used as the key to unlock this
                 data, going from hypothesis generation to model evaluation and
                 tool implementation. It is becoming more and more the heart of
                 bioinformatics workflows, enabling scientists to reason and
                 communicate more effectively. In parallel, there has been a
                 corresponding trend towards the development of related
                 software, which has triggered the maturation of different
                 visualisation libraries and frameworks. For bioinformaticians,
                 scientific programmers and software developers, the main
                 challenge is to pick out the most fitting one(s) to create
                 clear, meaningful and integrated data visualisation for their
                 particular use cases. In this review, we introduce a
                 collection of open source or free to use libraries and
                 frameworks for creating data visualisation, covering the
                 generation of a wide variety of charts and graphs. We will
                 focus on software written in Java, JavaScript or Python. We
                 truly believe this software offers the potential to turn
                 tedious data into exciting visual stories.",
  journal     = "Proteomics",
  volume      =  15,
  number      =  8,
  pages       = "1356--1374",
  month       =  apr,
  year        =  2015,
  url         = "http://dx.doi.org/10.1002/pmic.201400377",
  file        = "All Papers/W/Wang et al. 2015 - Open source libraries and frameworks for biological data visualisation - a guide for developers.pdf",
  keywords    = "Bioinformatics; Chart; Hierarchy; Network; Software library",
  language    = "en",
  issn        = "1615-9853, 1615-9861",
  pmid        = "25475079",
  doi         = "10.1002/pmic.201400377",
  pmc         = "PMC4409855"
}


@ARTICLE{Zhang2013-ul,
  title    = "{RCircos}: an {R} package for Circos {2D} track plots",
  author   = "Zhang, Hongen and Meltzer, Paul and Davis, Sean",
  abstract = "BACKGROUND: Circos is a Perl language based software package for
              visualizing similarities and differences of genome structure and
              positional relationships between genomic intervals. Running
              Circos requires extra data processing procedures to prepare plot
              data files and configure files from datasets, which limits its
              capability of integrating directly with other software tools such
              as R. Recently published R Bioconductor package ggbio provides a
              function to display genomic data in circular layout based on
              multiple other packages, which increases its complexity of usage
              and decreased the flexibility in integrating with other R
              pipelines. RESULTS: We implemented an R package, RCircos, using
              only R packages that come with R base installation. The package
              supports Circos 2D data track plots such as scatter, line,
              histogram, heatmap, tile, connectors, links, and text labels.
              Each plot is implemented with a specific function and input data
              for all functions are data frames which can be objects read from
              text files or generated with other R pipelines. CONCLUSION:
              RCircos package provides a simple and flexible way to make Circos
              2D track plots with R and could be easily integrated into other R
              data processing and graphic manipulation pipelines for presenting
              large-scale multi-sample genomic research data. It can also serve
              as a base tool to generate complex Circos images.",
  journal  = "BMC bioinformatics",
  volume   =  14,
  pages    = "244",
  month    =  jan,
  year     =  2013,
  url      = "http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3765848&tool=pmcentrez&rendertype=abstract",
  file     = "All Papers/Z/Zhang et al. 2013 - RCircos - an R package for Circos 2D track plots.pdf",
  keywords = "Animals; Computer Graphics; Gene Expression Profiling; Genome;
              Genome: genetics; Genomics; Genomics: instrumentation; Image
              Processing, Computer-Assisted; Mice; Rats; Software",
  issn     = "1471-2105",
  pmid     = "23937229",
  doi      = "10.1186/1471-2105-14-244"
}


@ARTICLE{Gu2016-xb,
  title       = "Complex heatmaps reveal patterns and correlations in
                 multidimensional genomic data",
  author      = "Gu, Zuguang and Eils, Roland and Schlesner, Matthias",
  affiliation = "Division of Theoretical Bioinformatics Heidelberg Center for
                 Personalized Oncology (DKFZ-HIPO), German Cancer Research
                 Center (DKFZ), Heidelberg, Germany. Division of Theoretical
                 Bioinformatics Heidelberg Center for Personalized Oncology
                 (DKFZ-HIPO), German Cancer Research Center (DKFZ), Heidelberg,
                 Germany Department for Bioinformatics and Functional Genomics,
                 Institute for Pharmacy and Molecular Biotechnology (IPMB) and
                 BioQuant, Heidelberg University, Heidelberg, Germany. Division
                 of Theoretical Bioinformatics.",
  abstract    = "Parallel heatmaps with carefully designed annotation graphics
                 are powerful for efficient visualization of patterns and
                 relationships among high dimensional genomic data. Here we
                 present the ComplexHeatmap package that provides rich
                 functionalities for customizing heatmaps, arranging multiple
                 parallel heatmaps and including user-defined annotation
                 graphics. We demonstrate the power of ComplexHeatmap to easily
                 reveal patterns and correlations among multiple sources of
                 information with four real-world datasets. AVAILABILITY AND
                 IMPLEMENTATION: The ComplexHeatmap package and documentation
                 are freely available from the Bioconductor project:
                 http://www.bioconductor.org/packages/devel/bioc/html/ComplexHeatmap.html
                 CONTACT: m.schlesner@dkfz.deSupplementary information:
                 Supplementary data are available at Bioinformatics online.",
  journal     = "Bioinformatics",
  month       =  "20~" # may,
  year        =  2016,
  url         = "http://dx.doi.org/10.1093/bioinformatics/btw313",
  file        = "All Papers/G/Gu et al. 2016 - Complex heatmaps reveal patterns and correlations in multidimensional genomic data.pdf",
  language    = "en",
  issn        = "1367-4803, 1367-4811",
  pmid        = "27207943",
  doi         = "10.1093/bioinformatics/btw313"
}



% The entry below contains non-ASCII chars that could not be converted
% to a LaTeX equivalent.
@ARTICLE{Gu2016-ir,
  title       = "gtrellis: an {R/Bioconductor} package for making genome-level
                 Trellis graphics",
  author      = "Gu, Zuguang and Eils, Roland and Schlesner, Matthias",
  affiliation = "Division of Theoretical Bioinformatics (B080), German Cancer
                 Research Center (DKFZ), Im Neuenheimer Feld 280, 69120,
                 Heidelberg, Germany. Heidelberg Center for Personalized
                 Oncology (DKFZ-HIPO), German Cancer Research Center (DKFZ), Im
                 Neuenheimer Feld 280, 69120, Heidelberg, Germany. Division of
                 Theoretical Bioinformatics (B080), German Cancer Research
                 Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg,
                 Germany. Heidelberg Center for Personalized Oncology
                 (DKFZ-HIPO), German Cancer Research Center (DKFZ), Im
                 Neuenheimer Feld 280, 69120, Heidelberg, Germany. Department
                 for Bioinformatics and Functional Genomics, Institute for
                 Pharmacy and Molecular Biotechnology (IPMB) and BioQuant
                 Center, Heidelberg University, Im Neuenheimer Feld 267, 69120,
                 Heidelberg, Germany. Division of Theoretical Bioinformatics
                 (B080), German Cancer Research Center (DKFZ), Im Neuenheimer
                 Feld 280, 69120, Heidelberg, Germany. m.schlesner@dkfz.de.",
  abstract    = "BACKGROUND: Trellis graphics are a visualization method that
                 splits data by one or more categorical variables and displays
                 subsets of the data in a grid of panels. Trellis graphics are
                 broadly used in genomic data analysis to compare statistics
                 over different categories in parallel and reveal multivariate
                 relationships. However, current software packages to produce
                 Trellis graphics have not been designed with genomic data in
                 mind and lack some functionality that is required for
                 effective visualization of genomic data. RESULTS: Here we
                 introduce the gtrellis package which provides an efficient and
                 extensible way to visualize genomic data in a Trellis layout.
                 gtrellis provides highly flexible Trellis layouts which allow
                 efficient arrangement of genomic categories on the plot. It
                 supports multiple-track visualization, which makes it
                 straightforward to visualize several properties of genomic
                 data in parallel to explain complex relationships. In
                 addition, gtrellis provides an extensible framework that
                 allows adding user-defined graphics. CONCLUSIONS: The gtrellis
                 package provides an easy and effective way to visualize
                 genomic data and reveal high dimensional relationships on a
                 genome-wide scale. gtrellis can be flexibly extended and thus
                 can also serve as a base package for highly specific purposes.
                 gtrellis makes it easy to produce novel visualizations, which
                 can lead to the discovery of previously unrecognized patterns
                 in genomic data.",
  journal     = "BMC bioinformatics",
  publisher   = "bmcbioinformatics.biomedcentral. ",
  volume      =  17,
  pages       = "169",
  month       =  "18~" # apr,
  year        =  2016,
  url         = "http://dx.doi.org/10.1186/s12859-016-1051-4",
  file        = "All Papers/G/Gu et al. 2016 - gtrellis - an R - Bioconductor package for making genome-level Trellis graphics.pdf",
  keywords    = "Genomic data visualization; Software; Trellis graphics",
  issn        = "1471-2105",
  pmid        = "27089965",
  doi         = "10.1186/s12859-016-1051-4",
  pmc         = "PMC4835841"
}


@ARTICLE{Zhang2016-lc,
  title       = "{caOmicsV}: an {R} package for visualizing multidimensional
                 cancer genomic data",
  author      = "Zhang, Hongen and Meltzer, Paul S and Davis, Sean R",
  affiliation = "Genetics Branch, Center for Cancer Research, National Cancer
                 Institute, National Institutes of Health, Building 37, Room
                 6138, 37 Convent Drive, Bethesda, MD, 20892-4265, USA.
                 Genetics Branch, Center for Cancer Research, National Cancer
                 Institute, National Institutes of Health, Building 37, Room
                 6138, 37 Convent Drive, Bethesda, MD, 20892-4265, USA.
                 Genetics Branch, Center for Cancer Research, National Cancer
                 Institute, National Institutes of Health, Building 37, Room
                 6138, 37 Convent Drive, Bethesda, MD, 20892-4265, USA.
                 sdavis2@mail.nih.gov.",
  abstract    = "BACKGROUND: Translational genomics research in cancers, e.g.,
                 International Cancer Genome Consortium (ICGC) and The Cancer
                 Genome Atlas (TCGA), has generated large multidimensional
                 datasets from high-throughput technologies. Data analysis at
                 multidimensional level will greatly benefit clinical
                 applications of genomic information in diagnosis, prognosis
                 and therapeutics of cancers. To help, tools to effectively
                 visualize integrated multidimensional data are important for
                 understanding and describing the relationship between genomic
                 variations and cancers. RESULTS: We implemented the R package,
                 caOmicsV, to provide methods under R environment to visualize
                 multidimensional cancer genomic data in two layouts: matrix
                 layout and combined biological network and circular layout.
                 Both layouts support to display sample information, gene
                 expression (e.g., RNA and miRNA), DNA methylation, DNA copy
                 number variations, and summarized data. A set of supplemental
                 functions are included in the caOmicsV package to help users
                 in generation of plot data sets from multiple genomic datasets
                 with given gene names and sample names. Default plot methods
                 for both layouts for easy use are also implemented.
                 CONCLUSION: caOmicsV package provides an easy and flexible way
                 to visualize integrated multidimensional cancer genomic data
                 under R environment.",
  journal     = "BMC bioinformatics",
  volume      =  17,
  pages       = "141",
  month       =  "22~" # mar,
  year        =  2016,
  url         = "http://dx.doi.org/10.1186/s12859-016-0989-6",
  file        = "All Papers/Z/Zhang et al. 2016 - caOmicsV - an R package for visualizing multidimensional cancer genomic data.pdf",
  keywords    = "Genomic data visualization; Multidimensional data
                 visualization; R package; Software",
  language    = "en",
  issn        = "1471-2105",
  pmid        = "27005934",
  doi         = "10.1186/s12859-016-0989-6",
  pmc         = "PMC4804509"
}


@ARTICLE{Colaprico2016-nj,
  title       = "{TCGAbiolinks}: an {R/Bioconductor} package for integrative
                 analysis of {TCGA} data",
  author      = "Colaprico, Antonio and Silva, Tiago C and Olsen, Catharina and
                 Garofano, Luciano and Cava, Claudia and Garolini, Davide and
                 Sabedot, Thais S and Malta, Tathiane M and Pagnotta, Stefano M
                 and Castiglioni, Isabella and Ceccarelli, Michele and
                 Bontempi, Gianluca and Noushmehr, Houtan",
  affiliation = "Interuniversity Institute of Bioinformatics in Brussels (IB),
                 Brussels, Belgium Machine Learning Group (MLG), Department
                 d'Informatique, Universit\'{e} libre de Bruxelles (ULB),
                 Brussels, Belgium. Department of Genetics Ribeir\~{a}o Preto
                 Medical School, University of S\~{a}o Paulo, Ribeir\~{a}o
                 Preto, S\~{a}o Paulo, Brazil Center for Integrative Systems
                 Biology - CISBi, NAP/USP, Ribeir\~{a}o Preto, S\~{a}o Paulo,
                 Brazil. Interuniversity Institute of Bioinformatics in
                 Brussels (IB), Brussels, Belgium Machine Learning Group (MLG),
                 Department d'Informatique, Universit\'{e} libre de Bruxelles
                 (ULB), Brussels, Belgium. Department of Science and
                 Technology, University of Sannio, Benevento, Italy Unlimited
                 Software srl, Naples, Italy. Institute of Molecular Bioimaging
                 and Physiology of the National Research Council (IBFM-CNR),
                 Milan, Italy. Physics for Complex Systems, Department of
                 Physics, University of Turin, Italy. Department of Genetics
                 Ribeir\~{a}o Preto Medical School, University of S\~{a}o
                 Paulo, Ribeir\~{a}o Preto, S\~{a}o Paulo, Brazil Center for
                 Integrative Systems Biology - CISBi, NAP/USP, Ribeir\~{a}o
                 Preto, S\~{a}o Paulo, Brazil. Department of Genetics
                 Ribeir\~{a}o Preto Medical School, University of S\~{a}o
                 Paulo, Ribeir\~{a}o Preto, S\~{a}o Paulo, Brazil Center for
                 Integrative Systems Biology - CISBi, NAP/USP, Ribeir\~{a}o
                 Preto, S\~{a}o Paulo, Brazil. Department of Science and
                 Technology, University of Sannio, Benevento, Italy
                 Bioinformatics Laboratory, BIOGEM, Ariano Irpino, Avellino,
                 Italy. Institute of Molecular Bioimaging and Physiology of the
                 National Research Council (IBFM-CNR), Milan, Italy. Qatar
                 Computing Research Institute (QCRI), HBKU, Doha, Qatar.
                 Interuniversity Institute of Bioinformatics in Brussels (IB),
                 Brussels, Belgium Machine Learning Group (MLG), Department
                 d'Informatique, Universit\'{e} libre de Bruxelles (ULB),
                 Brussels, Belgium gbonte@ulb.ac.be. Department of Genetics
                 Ribeir\~{a}o Preto Medical School, University of S\~{a}o
                 Paulo, Ribeir\~{a}o Preto, S\~{a}o Paulo, Brazil Center for
                 Integrative Systems Biology - CISBi, NAP/USP, Ribeir\~{a}o
                 Preto, S\~{a}o Paulo, Brazil houtan@usp.br.",
  abstract    = "The Cancer Genome Atlas (TCGA) research network has made
                 public a large collection of clinical and molecular phenotypes
                 of more than 10 000 tumor patients across 33 different tumor
                 types. Using this cohort, TCGA has published over 20 marker
                 papers detailing the genomic and epigenomic alterations
                 associated with these tumor types. Although many important
                 discoveries have been made by TCGA's research network,
                 opportunities still exist to implement novel methods, thereby
                 elucidating new biological pathways and diagnostic markers.
                 However, mining the TCGA data presents several bioinformatics
                 challenges, such as data retrieval and integration with
                 clinical data and other molecular data types (e.g. RNA and DNA
                 methylation). We developed an R/Bioconductor package called
                 TCGAbiolinks to address these challenges and offer
                 bioinformatics solutions by using a guided workflow to allow
                 users to query, download and perform integrative analyses of
                 TCGA data. We combined methods from computer science and
                 statistics into the pipeline and incorporated methodologies
                 developed in previous TCGA marker studies and in our own
                 group. Using four different TCGA tumor types (Kidney, Brain,
                 Breast and Colon) as examples, we provide case studies to
                 illustrate examples of reproducibility, integrative analysis
                 and utilization of different Bioconductor packages to advance
                 and accelerate novel discoveries.",
  journal     = "Nucleic acids research",
  volume      =  44,
  number      =  8,
  pages       = "e71",
  month       =  "5~" # may,
  year        =  2016,
  url         = "http://dx.doi.org/10.1093/nar/gkv1507",
  file        = "All Papers/C/Colaprico et al. 2016 - TCGAbiolinks - an R - Bioconductor package for integrative analysis of TCGA data.pdf",
  language    = "en",
  issn        = "0305-1048, 1362-4962",
  pmid        = "26704973",
  doi         = "10.1093/nar/gkv1507",
  pmc         = "PMC4856967"
}


@ARTICLE{Samur2014-vz,
  title       = "{RTCGAToolbox}: a new tool for exporting {TCGA} Firehose data",
  author      = "Samur, Mehmet Kemal",
  affiliation = "Department of Biostatistics and Computational Biology,
                 Dana-Farber Cancer Institute and Harvard School of Public
                 Health, Boston, Massachusetts, United States of America; Lebow
                 Institute of Myeloma Therapeutics and Jerome Lipper Multiple
                 Myeloma Center, Dana-Farber Cancer Institute and Harvard
                 Medical School, Boston, Massachusetts, United States of
                 America.",
  abstract    = "BACKGROUND \& OBJECTIVE: Managing data from large-scale
                 projects (such as The Cancer Genome Atlas (TCGA)) for further
                 analysis is an important and time consuming step for research
                 projects. Several efforts, such as the Firehose project, make
                 TCGA pre-processed data publicly available via web services
                 and data portals, but this information must be managed,
                 downloaded and prepared for subsequent steps. We have
                 developed an open source and extensible R based data client
                 for pre-processed data from the Firehouse, and demonstrate its
                 use with sample case studies. Results show that our
                 RTCGAToolbox can facilitate data management for researchers
                 interested in working with TCGA data. The RTCGAToolbox can
                 also be integrated with other analysis pipelines for further
                 data processing. AVAILABILITY AND IMPLEMENTATION: The
                 RTCGAToolbox is open-source and licensed under the GNU General
                 Public License Version 2.0. All documentation and source code
                 for RTCGAToolbox is freely available at
                 http://mksamur.github.io/RTCGAToolbox/ for Linux and Mac OS X
                 operating systems.",
  journal     = "PloS one",
  volume      =  9,
  number      =  9,
  pages       = "e106397",
  month       =  "2~" # sep,
  year        =  2014,
  url         = "http://dx.doi.org/10.1371/journal.pone.0106397",
  file        = "All Papers/S/Samur 2014 - RTCGAToolbox - a new tool for exporting TCGA Firehose data.pdf",
  language    = "en",
  issn        = "1932-6203",
  pmid        = "25181531",
  doi         = "10.1371/journal.pone.0106397",
  pmc         = "PMC4152273"
}


@ARTICLE{Wan2016-ol,
  title       = "{TCGA2STAT}: simple {TCGA} data access for integrated
                 statistical analysis in {R}",
  author      = "Wan, Ying-Wooi and Allen, Genevera I and Liu, Zhandong",
  affiliation = "Computational and Integrative Biomedical Research Center,
                 Department of Obstetrics and Gynecology, Baylor College of
                 Medicine, Houston, TX, USA. Department of Statistics and
                 Electrical \& Computer Engineering, Rice University, Houston,
                 TX, USA and Department of Pediatrics-Neurology, Jan and Dan
                 Duncan Neurological Research Institute, Texas Children's
                 Hospital, Baylor College of Medicine, Houston, TX, USA.
                 Computational and Integrative Biomedical Research Center,
                 Department of Pediatrics-Neurology, Jan and Dan Duncan
                 Neurological Research Institute, Texas Children's Hospital,
                 Baylor College of Medicine, Houston, TX, USA.",
  abstract    = "MOTIVATION: Massive amounts of high-throughput genomics data
                 profiled from tumor samples were made publicly available by
                 the Cancer Genome Atlas (TCGA). RESULTS: We have developed an
                 open source software package, TCGA2STAT, to obtain the TCGA
                 data, wrangle it, and pre-process it into a format ready for
                 multivariate and integrated statistical analysis in the R
                 environment. In a user-friendly format with one single
                 function call, our package downloads and fully processes the
                 desired TCGA data to be seamlessly integrated into a
                 computational analysis pipeline. No further technical or
                 biological knowledge is needed to utilize our software, thus
                 making TCGA data easily accessible to data scientists without
                 specific domain knowledge. AVAILABILITY AND IMPLEMENTATION:
                 TCGA2STAT is available from the
                 https://cran.r-project.org/web/packages/TCGA2STAT/index.html
                 SUPPLEMENTARY INFORMATION: Supplementary data are available at
                 Bioinformatics online. CONTACT: zhandong.liu@bcm.edu.",
  journal     = "Bioinformatics",
  volume      =  32,
  number      =  6,
  pages       = "952--954",
  month       =  "15~" # mar,
  year        =  2016,
  url         = "http://dx.doi.org/10.1093/bioinformatics/btv677",
  file        = "All Papers/W/Wan et al. 2016 - TCGA2STAT - simple TCGA data access for integrated statistical analysis in R.pdf",
  language    = "en",
  issn        = "1367-4803, 1367-4811",
  pmid        = "26568634",
  doi         = "10.1093/bioinformatics/btv677"
}

